glycycoumarin and Liver-Diseases

glycycoumarin has been researched along with Liver-Diseases* in 1 studies

Reviews

1 review(s) available for glycycoumarin and Liver-Diseases

ArticleYear
Protective effects of glycycoumarin on liver diseases.
    Phytotherapy research : PTR, 2020, Volume: 34, Issue:6

    Licorice, an edible and medicinal plant, has long been used to treat various diseases, including liver diseases. Glycycoumarin (GCM) is a representative coumarin compound in licorice with favorable bioavailability feature. Recent studies by us demonstrated that GCM is highly effective against alcoholic liver disease, nonalcoholic fatty liver disease, acetaminophen-induced hepatotoxicity, and liver cancer through mechanisms involved in activation of Nrf2 antioxidant system, stimulation of AMPK-mediated energy homeostasis, induction of autophagy degradation process, and inhibiting oncogenic kinase T-lymphokine-activated killer cell-originated protein kinase activity. In this review, we summarize the findings on the hepatoprotective effect of GCM, discuss the signaling pathways underlying GCM-induced protective effect on liver diseases, and propose the issues that need to be addressed to promote further development of GCM as a clinically useful hepatoprotective agent.

    Topics: Animals; Coumarins; Humans; Liver Diseases

2020